SVR A221a

规格:

货期:

编号:TS210844

品牌:Testobio

产品名称：	SVR A221a
商品货号：	TS210844
Organism：	Mus musculus, mouse
Tissue：	pancreas
Cell Type：	endothelialSV40 transformed
Product Format：	frozen
Culture Properties：	adherent
Biosafety Level：	2 Cells contain polyomavirus DNA sequences Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Strain：	C57BL/6
Applications：	SVR A221a is an endothelial cell line derived from the SVR cell line (ATCC CRL-2280). This cell line along with a wild type control SVR bag4 (ATCC CRL-2287) can be used to determine if drugs regulate the MAPKK pathway.
Storage Conditions：	liquid nitrogen vapor phase
Derivation：	SVR A221a is an endothelial cell line derived from the SVR cell line (ATCC CRL-2280).
Tumorigenic：	Yes
Effects：	Yes,
Comments：	SVR A221a is an endothelial cell line derived from the SVR cell line (ATCC CRL-2280). SVR is a hygromycin resistant mouse endothelial cell line containing a temperature sensitive SV40 large T-antigen and H-RAS oncogene. SVR cells were infected with a retrovirus encoding a dominant negative allele of the Mitogen-Activated Protein Kinase Kinase (MAPKK) gene A221a and selected in puromycin. RAS oncogenes upregulate two signal transduction pathways, the MAP Kinase Kinase and phosphoinositol-3-Kinase pathways. Dominant negative MAPKK causes decreased growth in vitro but not in vivo. This cell line along with a wild type control SVR bag4 (ATCC CRL-2287) can be used to determine if drugs regulate the MAPKK pathway.
Complete Growth Medium：	Dulbeccos modified Eagles medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 1.0 g/L glucose, 95%; fetal bovine serum, 5%
Subculturing：	Volumes used in this protocol are for 75 cm² flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Remove and discard culture medium. Briefly rinse the cell layer with 0.25% (w/v) Trypsin-0.53mM EDTA solution to remove all traces of serum which contains trypsin inhibitor. Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting. Add appropriate aliquots of the cell suspension to new culture vessels. Incubate cultures at 37°C. Subcultivation Ratio: 1:4 to 1:8 Medium Renewal: Every 2 to 3 days Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a Manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994.
Cryopreservation：	Complete growth medium described above supplemented with 5% (v/v) DMSO.xa0 Cell culture tested DMSO is available as ATCC Catalog No. 4-X.
Culture Conditions：	Temperature: 37°C Atmosphere: Air, 95%; Carbon dioxide (CO₂), 5%
Name of Depositor：	JL Arbiser
Deposited As：	mouse
References：	LaMontagne KR Jr., et al. Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. Am. J. Pathol. 157: 1937-1945, 2000. PubMed: 11106566 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online.

首页 > 产品中心 > 微生物培养 > 菌株 > null > SVR A221a

产品中心 Product Center

联系我们CONTACT US

0574-87917803
24小时服务热线
testobio@163.com
销售邮箱
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址

联系方式

章丽敏
17757489010
朱静
18067106081
李晴
18067408036
李晶晶
13375187189
周雪
13372109301

SVR A221a

货号: TS210844
好评

询价

品牌 : TESTOBIO

加入购物车在线咨询

产品名称：	SVR A221a
商品货号：	TS210844
Organism：	Mus musculus, mouse
Tissue：	pancreas
Cell Type：	endothelialSV40 transformed
Product Format：	frozen
Culture Properties：	adherent
Biosafety Level：	2 Cells contain polyomavirus DNA sequences Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Strain：	C57BL/6
Applications：	SVR A221a is an endothelial cell line derived from the SVR cell line (ATCC CRL-2280). This cell line along with a wild type control SVR bag4 (ATCC CRL-2287) can be used to determine if drugs regulate the MAPKK pathway.
Storage Conditions：	liquid nitrogen vapor phase
Derivation：	SVR A221a is an endothelial cell line derived from the SVR cell line (ATCC CRL-2280).
Tumorigenic：	Yes
Effects：	Yes,
Comments：	SVR A221a is an endothelial cell line derived from the SVR cell line (ATCC CRL-2280). SVR is a hygromycin resistant mouse endothelial cell line containing a temperature sensitive SV40 large T-antigen and H-RAS oncogene. SVR cells were infected with a retrovirus encoding a dominant negative allele of the Mitogen-Activated Protein Kinase Kinase (MAPKK) gene A221a and selected in puromycin. RAS oncogenes upregulate two signal transduction pathways, the MAP Kinase Kinase and phosphoinositol-3-Kinase pathways. Dominant negative MAPKK causes decreased growth in vitro but not in vivo. This cell line along with a wild type control SVR bag4 (ATCC CRL-2287) can be used to determine if drugs regulate the MAPKK pathway.
Complete Growth Medium：	Dulbeccos modified Eagles medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 1.0 g/L glucose, 95%; fetal bovine serum, 5%
Subculturing：	Volumes used in this protocol are for 75 cm² flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Remove and discard culture medium. Briefly rinse the cell layer with 0.25% (w/v) Trypsin-0.53mM EDTA solution to remove all traces of serum which contains trypsin inhibitor. Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting. Add appropriate aliquots of the cell suspension to new culture vessels. Incubate cultures at 37°C. Subcultivation Ratio: 1:4 to 1:8 Medium Renewal: Every 2 to 3 days Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a Manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994.
Cryopreservation：	Complete growth medium described above supplemented with 5% (v/v) DMSO.xa0 Cell culture tested DMSO is available as ATCC Catalog No. 4-X.
Culture Conditions：	Temperature: 37°C Atmosphere: Air, 95%; Carbon dioxide (CO₂), 5%
Name of Depositor：	JL Arbiser
Deposited As：	mouse
References：	LaMontagne KR Jr., et al. Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cells. Am. J. Pathol. 157: 1937-1945, 2000. PubMed: 11106566 Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC. Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988. Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online.